Big Pharma is Testing a Pill for COVID (It s Not Ivermectin) newsweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsweek.com Daily Mail and Mail on Sunday newspapers.
As the pandemic in the US slows, the fight against post-Covid syndrome is on msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
/
Nurse Janet Gilleran prepares to treat COVID-19 patient Mike Mokler with bamlanivimab, a monoclonal antibody drug from Eli Lilly, at the Respiratory Infection Clinic of Tufts Medical Center in Boston on Dec. 31, 2020. // Boston Globe via Getty Images, Craig F. Walker
Many doses of the monoclonal antibody drugs that treat mild to moderate COVID-19 are sitting unused around the country. There are logistical problems with providing these drugs and skepticism over whether they work. But two major health systems have had good success in deploying these medications, and they re reporting hopeful results.
Monoclonal antibodies, manufactured by Regeneron and Eli Lilly, have been available since just before Thanksgiving. The Food and Drug Administration authorized them for emergency use after studies suggested that they reduced the risk of hospitalization among people at elevated risk. That includes people over 65 and those with underlying health conditions such as obesity.